Mon, December 18, 2023

Alex Thompson Maintained (ACRS) at Hold with Decreased Target to $1 on, Dec 18th, 2023

Alex Thompson of Stifel, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Hold with Decreased Target from $2 to $1 on, Dec 18th, 2023.

Alex has made no other calls on ACRS in the last 4 months.



There are 4 other peers that have a rating on ACRS. Out of the 4 peers that are also analyzing ACRS, 2 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Louise Chen of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Tuesday, November 14th, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Monday, November 13th, 2023


These are the ratings of the 2 analyists that currently disagree with Alex


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $9 on, Tuesday, November 14th, 2023
  • Gavin Clark-Gartner of "Evercore ISI Group" Initiated at Buy and Held Target at $22 on, Tuesday, October 3rd, 2023